Medical Breakthrough: First-ever 3-D Colour X-ray performed on a human

Published On 2018-07-14 10:08 GMT   |   Update On 2018-07-14 10:08 GMT

The machine's "small pixels and accurate energy resolution meant that this new imaging tool is able to get images that no other imaging tool can achieve," said developer Phil Butler of the University of Canterbury.Paris:  New Zealand scientists have performed the first-ever 3-D, colour X-ray on a human, using a technique that promises to improve the field of medical diagnostics, said...

Login or Register to read the full article
The machine's "small pixels and accurate energy resolution meant that this new imaging tool is able to get images that no other imaging tool can achieve," said developer Phil Butler of the University of Canterbury.

Paris:  New Zealand scientists have performed the first-ever 3-D, colour X-ray on a human, using a technique that promises to improve the field of medical diagnostics, said Europe's CERN physics lab which contributed imaging technology.

The new device, based on the traditional black-and-white X-ray, incorporates particle-tracking technology developed for CERN's Large Hadron Collider, which in 2012 discovered the elusive Higgs Boson particle.

"This colour X-ray imaging technique could produce clearer and more accurate pictures and help doctors give their patients more accurate diagnoses," said a CERN statement.
The CERN technology, dubbed Medipix, works like a camera detecting and counting individual sub-atomic particles as they collide with pixels while its shutter is open. This allows for high-resolution, high-contrast pictures.

The machine's "small pixels and accurate energy resolution meant that this new imaging tool is able to get images that no other imaging tool can achieve," said developer Phil Butler of the University of Canterbury.

According to the CERN, the images very clearly show the difference between bone, muscle and cartilage, but also the position and size of cancerous tumours, for example.

The technology is being commercialised by New Zealand company MARS Bioimaging, linked to the universities of Otago and Canterbury which helped develop it.
Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News